3rd Cell Therapy for Autoimmune Disease Summit
Over the past year autoimmune cell therapies has seen billion-dollar investments, consistent innovation, and success stories, positioning this space as one of the fastest growing in the industry. Are you ready for what’s next?
Join the explosion of companies pursuing non-oncology indications in cell therapy development at the 3rd Cell Therapy for Autoimmune Disease Summit.
Hear emerging trends, the latest clinical data, proven strategies and first-hand experiences to deepen your understanding of this field and discover where you might fit into its ongoing growth.
A quick preview of what is waiting for you this December:
- Access to 30+ expert thought leaders at the forefront of cell therapy autoimmune innovation, delving into assay development, antibody and cell targeting, treatment persistence, and patient recruitment.
- The latest insights and clinical readouts from biopharma pioneers at Orbital Therapeutics, PolTREG, Nkarta Therapeutics, Overland Pharmaceuticals and more.
- 3 days of tailored learnings with our tracked format, providing strategies to accelerate progression from discovery through to clinical trials.
- An opportunity to build new connections and strategic partnerships with the right partners to drive your therapeutic development forward.
Find the complete details in your copy of the agenda.
Size your chance to gather with industry colleagues in the combined goal of propelling best-in-class CAR-T, NK, in vivo, and Treg cell therapies to autoimmune patients in need!
